AI assistant
Sending…
CIMPRESS plc — Director's Dealing 2014
Dec 2, 2014
31904_dirs_2014-12-02_2509f5b8-31ff-43ca-9cb1-eabe9fe3f154.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CIMPRESS N.V. (CMPR)
CIK: 0001262976
Period of Report: 2014-11-30
Reporting Person: TEUNISSEN ERNST (Chief Financial Officer, Member of Management Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-30 | Ordinary Shares | M | 1020 | $0.00 | Acquired | 22117 | Direct |
| 2014-11-30 | Ordinary Shares | F | 440 | $67.09 | Disposed | 21677 | Direct |
| 2014-12-01 | Ordinary Shares | M | 920 | $0.00 | Acquired | 22597 | Direct |
| 2014-12-01 | Ordinary Shares | F | 397 | $67.09 | Disposed | 22200 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-11-30 | Restricted Share Units (right to acquire) | $0.00 | M | 1020 | Disposed | 2017-05-31 | Ordinary Shares (1020) | Direct |
| 2014-12-01 | Restricted Share Units (right to acquire) | $0.00 | M | 920 | Disposed | 2015-03-01 | Ordinary Shares (920) | Direct |
Footnotes
F1: The shares acquired represent the number of shares that automatically vested pursuant to a grant of restricted share units ("RSUs").
F2: Each RSU represents Cimpress' commitment to issue one ordinary share when the RSU vests.
F3: These RSUs vest over a four year period: 25% of the original number of shares vest on the Exercisable Date shown in Table II and 6.25% vest per quarter thereafter.
More from CIMPRESS plc
Regulatory Filings
2026
May 11
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 2
Interim / Quarterly Report
2026
Jan 29
Regulatory Filings
2026
Jan 28